Elite Pharmaceuticals, Inc. Convertible Notes Payable, Current
Elite Pharmaceuticals, Inc. (ELTP) had Convertible Notes Payable, Current of $6.07 million as of 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2014-02-14
- 2013-12-31: Convertible Notes Payable, Current $6.07M.
- 2013-09-30: Convertible Notes Payable, Current $5.78M.
- 2013-03-31: Convertible Notes Payable, Current $0.00.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2013-12-31 | $6.07M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $5.78M 10-Q · filed 2013-11-14 |
| 2013-03-31 | $0.00 10-Q · filed 2014-02-14 |